Clinical research - Press Releases

Date	Title	Company
25-Nov-2020	GSK starts phase 3 study of RSV maternal candidate vaccine	GSK
25-Nov-2020	AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19	Astra Zeneca
25-Nov-2020	Genmab Announces Enapotamab Vedotin Update	Genmab
24-Nov-2020	Actimed Therapeutics Licenses Additional European Patent Rights to S-oxprenolol in ALS from Charité – Universitätsmedizin Berlin	Actimed Therapeutics
24-Nov-2020	Coeliac UK and Innovate UK announce the award from their 2019 research call	Coeliac UK
20-Nov-2020	SMi’s 2nd Annual AI in Drug Discovery Announces key industry speakers and agenda released	SMi Group
20-Nov-2020	Research begins at pioneering centre aimed at overcoming cancer’s ability to evolve resistance to treatment	The Institute of Cancer Research
19-Nov-2020	Sensyne Health achieves five million patient target set at IPO	Sensyne Health
19-Nov-2020	Sensyne Health appoints President, North America, to lead US expansion	Sensyne Health
19-Nov-2020	One week to go Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology	SMi Group
19-Nov-2020	European Medicines Agency Begins Rolling Review of Moderna’s mRNA Vaccine Candidate Against COVID-19 (mRNA-1273)	Moderna
18-Nov-2020	HRA PHARMA’S MISSED PILLS STUDY CHALLENGES CURRENT NATIONAL GUIDELINES ON RESUMING REGULAR HORMONAL CONTRACEPTIVES AFTER TAKING ELLAONE®	HRA Pharma
16-Nov-2020	UK government’s response to Moderna’s publication of efficacy data for its COVID-19 vaccine	gov.uk
16-Nov-2020	Q BioMed’s Uttroside-B Receives U.S. Patent in Treatment of Liver Cancer	Q BioMed Inc
16-Nov-2020	OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing	Moberg Pharma
16-Nov-2020	Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering	Envision Pharma Group
16-Nov-2020	Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer	Myricx Pharma
16-Nov-2020	Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study	Moderna, Inc
16-Nov-2020	Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent	Bone Therapeutics
16-Nov-2020	Calypso Biotech Announces Successful Dosing of First Phase 1 Cohort with Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 for the Treatment of Autoimmune Diseases	Calypso Biotech